drugset / Trial / NCT01707901

A Study of the Effect of ONO-8539 on Oesophageal Pain Hypersensitivity in Patients With Non-erosive Reflux Disease

NCT01707901

Phase 1 Completed 14 enrolled Ono Pharmaceutical Co., Ltd.
RandomizedCrossoverDouble-blindTreatment

Summary

A random controlled study to investigate the effect of a new drug, ONO-8539, on oesophageal pain hypersensitivity in patients with gastric reflux disease

Timeline

Start
2012-12
Primary completion
2014-10
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject ONO-8539 Small molecule